Previous 10 | Next 10 |
2023-10-30 15:11:22 ET More on Novartis, Novartis AG, etc. New And Improved Novartis Novartis AG (NVS) Q3 2023 Earnings Call Transcript Novartis AG (NVS) Shareholder Analyst Call (Transcript) Novartis reports Q3 earnings boosted by strong sales of key drugs a...
2023-10-29 23:51:13 ET Summary Novartis recently completed the spin-off of Sandoz which improved its growth and margin profile. The biopharma business is in good shape with a decent collection of high-growth products and pipeline opportunities. The recent share price correctio...
2023-10-29 08:28:00 ET As the calendar turns from October to November, the week promises a flurry of earnings reports from some of the world's most prominent companies. Among the key players stepping into the earnings spotlight will be technology giant Apple ( NASDAQ: AAPL ), semico...
2023-10-28 06:50:00 ET Benjamin Franklin would probably be disappointed that the $100 bill that bears his likeness isn't worth what it used to be. However, there are actually plenty of great stocks to be found that you can buy with just one Benjamin. Three Motley Fool contributors think...
2023-10-27 07:35:00 ET Summary Investors are worried about soaring interest rates, a pending government shutdown, wars around the world, and a recession looming next year. History is very clear, market timing is the WORST thing you can possibly try. None of the best investors in h...
2023-10-27 05:05:00 ET Share prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular, immunology, neuroscience, solid tumors, and hematology therapies, and in early October completed the spinoff o...
2023-10-24 15:00:19 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q3 2023 Earnings Call Oct 24, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
2023-10-24 13:55:26 ET Novartis AG (NVS) Q3 2023 Earnings Call Transcript October 24, 2023, 08:00 AM ET Company Participants Samir Shah - Global Head of Investor Relations Vas Narasimhan - Chief Executive Officer Harry Kirsch - Chief Financial Officer Confe...
2023-10-24 11:23:00 ET Summary Ambrx Biopharma Inc. common stock experienced an irrational selloff following the Phase 1/2 ESMO data release for its ADC candidate ARX517, presenting a buying opportunity. The company's technology for next-generation ADCs has shown safety benefits a...
2023-10-24 11:09:02 ET Novartis AG. (NVS) Shareholder Analyst Call October 24, 2023, 07:00 AM ET Company Participants Samir Shah - Global Head, Investor Relations Shreeram Aradhye - Global Head of Development & Chief Medical Officer for Novartis Jeff Legos - ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...